MedTrace Logo

fungalAi for Fungal Surveillance & Antifungal Stewardship

NCT03793231 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-10-23

No results posted yet for this study

Summary

This national Australian study will validate and implement an effective approach to real-time electronic surveillance of fungal infections in patients with blood cancers using technology based on artificial intelligence. It will establish metrics for antifungal stewardship allowing benchmarking of these programs; provide decision support for radiologist interpretation of chest imaging and improve reporting, audit and feedback practices in hospitals where these infections are managed.

Conditions

  • Fungal Infections

Interventions

COMBINATION_PRODUCT

fungalAi platform technology

Electronic surveillance and radiologic diagnosis of invasive fungal infections using fungalAi and associated methodologies.

Sponsors & Collaborators

  • Monash University

    collaborator OTHER

  • Monash Health

    collaborator OTHER

  • Eastern Health

    collaborator OTHER

  • Western Sydney Local Health District

    collaborator OTHER

  • SA Health

    collaborator OTHER

  • Fremantle Hospital and Health Service

    collaborator OTHER

  • Singhealth Foundation

    collaborator OTHER_GOV

  • Bayside Health

    lead OTHER_GOV

Principal Investigators

  • Michelle Dr Ananda-Rajah · The Alfred

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793231 on ClinicalTrials.gov